Breaking News Instant updates and real-time market news.

HRS

Harris

$149.60

2.54 (1.73%)

09:01
11/06/18
11/06
09:01
11/06/18
09:01

Harris receives NSA certification for AN/PRC-163 handheld radio

Harris Corporation has received National Security Agency Type-1 certification for its AN/PRC-163 multi-channel handheld networking radio - bringing groundbreaking capabilities to the warfighter, with the ability for future expansion. The Harris AN/PRC-163 combines communications and intelligence, surveillance and reconnaissance capabilities to address the users' unique mission needs in a small, portable form factor. This certification allows the radio to transmit secure voice and data communications up to Top Secret level on both channels for VHF/UHF line of sight, SATCOM and Mobile Ad-Hoc Networking applications.

HRS Harris
$149.60

2.54 (1.73%)

10/15/18
FBCO
10/15/18
NO CHANGE
Target $209
FBCO
Outperform
Harris price target raised to $209 from $190 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Harris (HRS) to $209 from $190 after the company and L3 Technologies (LLL) announced an all-stock merger of equals. The analyst believes this could be "the most strategically significant and shareholder friendly" M&A deal announced since the start of the current A&D consolidation wave. He reiterates an Outperform rating on Harris' shares.
10/15/18
FBCO
10/15/18
NO CHANGE
Target $272
FBCO
Outperform
L3 Technologies price target raised to $272 from $238 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for L3 Technologies (LLL) to $272 from $238 after the company and Harris (HRS) announced an all-stock merger of equals. Though some may read into Harris buying L3 Technologies, the analyst sees this as a true merger of equals. He reiterates an Outperform rating on L3 Technologies' shares.
10/15/18
JEFF
10/15/18
NO CHANGE
Target $184
JEFF
Buy
Harris, L3 should trade up 5% on merger deal, says Jefferies
Jefferies analyst Sheila Kahyaoglu believes both Harris (HRS) and L3 Technologies (LLL) should trade up 5% following the announced merger of equals. The analyst bases this on the combined company's $3B of free cash flow generation in 2022and a 6.5% free cash flow yield, discounted back. She has a Buy rating on Harris and Hold rating on L3. Harris in premarket trading is up 5.4% to $163.25 while L3 is up 6.7% to $208.89.
11/02/18
JPMS
11/02/18
DOWNGRADE
Target $240
JPMS
Neutral
L3 Technologies downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Seth Seifman downgraded L3 Technologies (LLL) to Neutral and lowered his price target for the shares to $240 from $245. The analyst views Harris (HRS) as the better way to gain exposure to the proposed merger. He keeps an Overweight rating on Harris with a $190 price target.

TODAY'S FREE FLY STORIES

BE

Bloom Energy

$16.04

0.56 (3.62%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
Bloom Energy enters strategic partnership with SK E&C »

SK Group and Bloom Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

DRRX

Durect

$0.91

-0.0094 (-1.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
Durect amends ongoing Phase 2a trial of DUR-928 »

Durect announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$180.35

-0.03 (-0.02%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Hot Stocks
CACI awarded $413M contract for U.S. Army communications systems support »

CACI International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$37.44

-1.13 (-2.93%)

08:07
11/19/18
11/19
08:07
11/19/18
08:07
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

MGTA

Magenta Therapeutics

$7.50

0.4 (5.63%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Magenta Therapeutics names Jason Ryan as Chief Operating and Financial Officer »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

NERV

Minerva

$8.41

0.11 (1.33%)

08:06
11/19/18
11/19
08:06
11/19/18
08:06
Hot Stocks
Minerva announces results from roluperidone study »

Minerva announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BKI

Black Knight

$49.77

0.87 (1.78%)

, DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

08:05
11/19/18
11/19
08:05
11/19/18
08:05
Hot Stocks
Black Knight board approves $375M investment in Dun & Bradstreet »

Black Knight (BKI)…

BKI

Black Knight

$49.77

0.87 (1.78%)

DNB

Dun & Bradstreet

$142.27

0.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 03

    Dec

CMP

Compass Minerals

$52.49

0.98 (1.90%)

08:04
11/19/18
11/19
08:04
11/19/18
08:04
Hot Stocks
Compass Minerals CEO to step down, Dick Grant named interim CEO »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LANC

Lancaster Colony

$182.53

-0.21 (-0.11%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Lancaster Colony acquires assets of Omni Baking Company for $25M »

Lancaster Colony…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENX

Tenax Therapeutics

$3.80

(0.00%)

08:03
11/19/18
11/19
08:03
11/19/18
08:03
Hot Stocks
Tenax activates first clinical research site for Phase 2 trial of levosimendan »

Tenax Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

, SRPT

Sarepta

$119.02

0.14 (0.12%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Conference/Events
Morgan Stanley to hold a bus trip »

Biotech Boston Bus Trip…

SLDB

Solid Biosciences

$33.82

2.81 (9.06%)

SRPT

Sarepta

$119.02

0.14 (0.12%)

NTGN

Neon Therapeutics

$6.98

-0.1 (-1.41%)

EDIT

Editas Medicine

$29.00

0.92 (3.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:02
11/19/18
11/19
08:02
11/19/18
08:02
Hot Stocks
NextEra Energy Transmission to acquire Trans Bay Cable for approximately $1B »

NextEra Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

KMB

Kimberly-Clark

$111.22

0.43 (0.39%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Periodicals
Kimberly-Clark won't sell European tissue business with bids too low, FT says »

Kimberly-Clark will call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Bernstein to hold a symposium »

5th Annual Asset…

NEE

NextEra Energy

$180.41

1.27 (0.71%)

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Hot Stocks
Breaking Hot Stocks news story on NextEra Energy »

NextEra Energy to acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

08:01
11/19/18
11/19
08:01
11/19/18
08:01
Conference/Events
Wedbush to hold a tour »

2018 Holiday Shopping…

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

08:00
11/19/18
11/19
08:00
11/19/18
08:00
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Upgrade
Sandy Spring Bancorp rating change  »

Sandy Spring Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBH

Sally Beauty

$20.61

-0.425 (-2.02%)

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Recommendations
Sally Beauty analyst commentary  »

Sally Beauty price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHLD

National Holdings Corp

$2.96

(0.00%)

07:57
11/19/18
11/19
07:57
11/19/18
07:57
Hot Stocks
Breaking Hot Stocks news story on National Holdings Corp »

National Holdings Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QIWI

Qiwi

$14.15

-0.28 (-1.94%)

07:55
11/19/18
11/19
07:55
11/19/18
07:55
Conference/Events
Qiwi to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

MDGL

Madrigal Pharmaceuticals

$129.47

-3.36 (-2.53%)

07:54
11/19/18
11/19
07:54
11/19/18
07:54
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BAX

Baxter

$66.49

0.68 (1.03%)

07:54
11/19/18
11/19
07:54
11/19/18
07:54
Recommendations
Baxter analyst commentary  »

Baxter confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 05

    Dec

LONE

Lonestar Resources

$7.03

-0.32 (-4.35%)

07:52
11/19/18
11/19
07:52
11/19/18
07:52
Hot Stocks
Lonestar Resources announces Eagle Ford shale acquisition »

Lonestar Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

, GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

07:52
11/19/18
11/19
07:52
11/19/18
07:52
Recommendations
Alphabet Class A, Alphabet, Oracle analyst commentary  »

JMP says former Oracle…

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

ORCL

Oracle

$51.19

0.55 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.